RLBCX
Price
$34.14
Change
+$0.26 (+0.77%)
Updated
Dec 20 closing price
SVBIX
Price
$28.67
Change
-$0.59 (-2.02%)
Updated
Dec 20 closing price
Ad is loading...

RLBCX vs SVBIX

Header iconRLBCX vs SVBIX Comparison
Open Charts RLBCX vs SVBIXBanner chart's image
American Funds American Balanced R3
Price$34.14
Change+$0.26 (+0.77%)
VolumeN/A
CapitalizationN/A
JHancock Balanced I
Price$28.67
Change-$0.59 (-2.02%)
VolumeN/A
CapitalizationN/A
RLBCX vs SVBIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RLBCX vs. SVBIX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLBCX is a Buy and SVBIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 236B vs. SVBIX (5.49B). RLBCX pays higher dividends than SVBIX: RLBCX (1.98) vs SVBIX (1.57). RLBCX was incepted earlier than SVBIX: RLBCX (23 years) vs SVBIX (23 years). RLBCX is a more actively managed with annual turnover of: 171.00 vs. SVBIX (62.00). RLBCX has a lower initial minimum investment than SVBIX: RLBCX (250) vs SVBIX (250000). SVBIX annual gain was more profitable for investors over the last year : 12.15 vs. RLBCX (9.82). SVBIX return over 5 years is better than : 44.05 vs. RLBCX (28.29).
RLBCXSVBIXRLBCX / SVBIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years23 years-
Gain YTD9.23311.67879%
Front LoadN/AN/A-
Min. Initial Investment2502500000%
Min. Initial Investment IRAN/AN/A-
Net Assets236B5.49B4,296%
Annual Yield % from dividends1.981.57125%
Returns for 1 year9.8212.1581%
Returns for 3 years8.6912.3171%
Returns for 5 years28.2944.0564%
Returns for 10 years48.7472.3367%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RDVT37.810.57
+1.53%
Red Violet
PPG120.210.69
+0.58%
PPG Industries
CAR80.980.04
+0.05%
Avis Budget Group
ADEA13.66-0.07
-0.51%
Adeia
TPST0.71-0.01
-1.17%
Tempest Therapeutics